48.7B

Nov. 3 (UPI) — The Texas-based Kimberly-Clark Corporation announced Monday it reached a deal to purchase Kenvue — the maker of Band-Aid and Tylenol products — for $48.7 billion.

The combination cash and stock transaction will see Kimberly-Clark acquire all outstanding shares of Kenvue common stock. A news release from Kimberly-Clark said the sale will put 10 billion-dollar brands together under the same company.

Kimberly-Clark’s brands include Kleenex, Cottonelle, Huggies, Poise, Pull-Ups, Scott, Viva and Kotex.

“We are excited to bring together two iconic companies to create a global health and wellness leader,” CEO Mike Hsu said.

“With a shared commitment to developing science and technology to provide extraordinary care, we will serve billions of consumers across every stage of life.”

Kimberly-Clark said the sale is expected to close in the second half of 2026 upon approval by shareholders of both companies. Upon completion, Hsu will serve as chairman of the board and CEO of the combined company. Meanwhile, three board members from Kenue will join Kimberly-Clark’s board.

In the wake of the news, Kenvue’s shares increased 20% in premarket trading, and Kimberly-Clark’s decreased by 14% Monday, CNBC reported.

Less than a week before the announcement, Texas Attorney General Ken Paxton announced he was suing Kenvue and its parent company, Johnson & Johnson, for “deceptively marketing” Tylenol as a safe pain reliever.

The Trump administration announced in September that there was a link between Tylenol and an increased risk of autism, though, on Thursday, Health and Human Services Secretary Robert F. Kennedy said there wasn’t sufficient evidence to explicitly claim that Tylenol causes autism.